Linkedin Facebook Twitter Youtube

19 Jul FibroBiologics

Posted at 20:03h in by

Hamid Khoja, Ph.D., Chief Scientific Officer

Oct. 7 | 2:15pm | FLW Ballroom F

Houston, TX

(NASDAQ:FBLG)

FibroBiologics is a clinical-stage biotechnology company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. Our proprietary fibroblast platform serves as the foundation for developing biologic cures and treatments for chronic diseases, including wound healing multiple sclerosis, degenerative disc disease, psoriasis, cancer, and anti-aging extension of life applications such as thymic involution reversal. Currently, FibroBiologics holds 240+ U.S. and International issued/pending patents across a variety of clinical pathways, including wound healing, multiple sclerosis, cartilage repair, psoriasis, degenerative disc, cancer, and extension of life programs.

www.FibroBiologics



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions